Redeye’s view on the Q2 report. The organic growth trend continues to be weak, although the situatio...
Redeye updates its estimates and valuation following Mentice’s Q2 2023 report.
SRV reported Q2 figures that were lower than we estimated for both net sales (EUR 141.
- Operational metrics continue to improve - Executing on its project potential - Bond maturities in ...
Redeye states that Advenica’s Q2 report was stronger than our estimates on topline.
- Nettoomsättningen och EBITDA-resultatet kom in starkare än väntat - De återkommande intäkterna ök...
6% organisk tillväxt… Marknadsläget är fortsatt stabilt för de flesta av koncernens verksamheter och...
Q2-resultatet svagare än väntat men visar ändå på styrka i en svår marknad Nettoomsättningen minskad...
VEF's share price is down 12% in SEK YTD despite: 1) a 25% recovery in its NAV YTD (in USD), which l...
• Two large regions in Sweden restrict staffing... • .
• Sales -8% vs. ABGSCe • Adj. EBITDA -44% vs. ABGSCe • Discontinuations have begun Q2'23 report The ...
Redeye comments on Tessin’s Q2 results, which showed solid sales numbers but lower profitability tha...
Safeture reported a good Q2 2023, with the ARR growing in line with its financial target of 30% a ye...
SRV's net sales in Q2 amounted to EUR 143.1m, below our estimate of EUR 156.
Innofactor’s Q2 saw continued good growth, better than anticipated, up 18.
Some of Vaisala's industrial customers have recently postponed their investment decisions which was ...
• Market saw a further sequential slowdown in Q2 • We cut '23e-'25e sales 9-3% on the weaker outlook...
• ARR +8% y-o-y, in line with ABGSCe • Cons. likely to make marginally pos.
Redeye comments on SDS’s Q2 results, which showed higher sales and profitability than expected.
Hansa delivers positive sales in Q2 and SEK 30m of product sales is the highest lever within a year.
